RELATED: Moderna says its coronavirus vaccine candidate is 94.5% effectiveOnce a vaccine gets a green light from the Food and Drug Administration, the panel will look at clinical trial data on side effects and how people of various ages, ethnicities and health statuses responded.
That will determine the panel's recommendations to the CDC on how to prioritize shots.State officials are expected to follow the CDC's guidance as they distribute the first vaccines.AdvertisementRELATED: Pfizer says early data signals COVID-19 vaccine is 90% effectiveVaccine supplies will be limited at first.
Read more on fox29.com